The Xylosyltransferase I Gene Polymorphism C.343g>t (P.a125s) is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes.
From: Institut für Laboratoriums und Transfusionsmedizin, Herz und Diabeteszentrum Nordrhein-Westfalen, 32545 Bad Oeynhausen, Germany.
Diabetes care
- Publish Date: Oct 2006
- ISSN: 0149-5992
- Volume: 29
- Issue: 10
- Pages: 2295-9
- Medium: Print
- Language: English
- Citation (JAMA): Schön Sylvia, Prante Christian, Bahr Claudia, et al. The Xylosyltransferase I Gene Polymorphism C.343g>t (P.a125s) is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes.. Diabetes Care Oct 2006;29:2295-9
Abstract
OBJECTIVE: Xylosyltransferase I (XT-I) is the chain-initiating enzyme in the biosynthesis of proteoglycans in basement membranes. It catalyzes the transfer of xylose to selected serine residues in the core protein. The XYLT-II gene codes for a protein highly homologous to XT-I. Proteoglycans are important components of basement membranes and are responsible for their permeability properties. Type 1 diabetic patients have an altered proteoglycan metabolism, which results in microvascular complications. Thus, genetic variations in the xylosyltransferase genes might be implicated in the initiation and progression of these complications. RESEARCH DESIGN AND METHODS: Genotyping of four genetic variations in the genes XYLT-I and XYLT-II was performed in 912 type 1 diabetic patients (453 with and 459 without diabetic nephropathy) using restriction fragment-length polymorphism. RESULTS: The distribution of the c.343G>T polymorphism in XYLT-I is significantly different between patients with and without diabetic nephropathy (P = 0.03). T-alleles were more frequent in patients with diabetic nephropathy (odds ratio 2.47 [95% CI 1.04-5.83]). The allelic frequencies of the other investigated XYLT-I and XYLT-II variations (XYLT-I: c.1989T>C in exon 9; XYLT-II: IVS6-9T>C and IVS6-14_IVS6-13insG in intron 5; and c.2402C>G: p.T801R in exon 11) were not different between patients with and without diabetic nephropathy. CONCLUSIONS: The XYLT-I c.343G>T polymorphism contributes to the genetic susceptibility to development of diabetic nephropathy in type 1 diabetic patients.
Mesh Headings (Keywords): Adult, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Gene Frequency, Genetic Predisposition to Disease, Genotype, Humans, Male, Middle Aged, Pentosyltransferases, Phenotype, Polymorphism, Single Nucleotide, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 17003309
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.